Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | OBE | HPK |
|---|---|---|
| Price | $10.63 | $8.52 |
| Change today | ▲ 0.09% | ▲ 3.65% |
| Market cap | $709.29M | $1.08B |
| Return, 3 months | +24.8% | +21.7% |
| Return, year to date | +73.4% | +79.7% |
| Return, 1 year | +54.7% | +21.6% |
| P/E (TTM) | 36.0 | -12.5 |
| P/B | 0.7 | 0.7 |
| P/E percentile vs own 5y | 92nd | 0th |
| Dividend yield | – | 0.94% |
| Revenue growth (YoY, latest qtr) | +43.7% | +25.8% |
| Net profit growth (YoY) | +174.5% | +214.3% |
| Gross margin | 56.9% | 21.5% |
| Operating margin | 13.3% | 15.7% |
| Net margin | 4.6% | -9.8% |
| Return on equity | 2.0% | -5.3% |
| Analyst target vs. price | +25.7% | +17.4% |
| Analyst buy share | 50% | 100% |
| RSI (14) | 42 | 59 |
| 30-day volatility | 47.6% | 49.3% |
| Max drawdown, 1 year | -45.6% | -46.7% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
